# Rydex NASDAQ-100 Inv (RYOCX)

> Source: Nexqual · https://nexqual.com/RYOCX · data as of 2026-10-24 00:08 UTC · cite as "Nexqual, Rydex NASDAQ-100 Inv (RYOCX), nexqual.com/RYOCX" · informational, not investment advice.

**Price:** USD 107.61 (-0.02% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 107.61 · day 107.61–107.61 · 52w 85.64–116.11 · market cap null · NAS

## Key facts
- Total return with dividends: 1Y +13.5% vs S&P 500 +13.4%; 5Y +78.1% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +13.5% | +78.1% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +13.5% | +12.3% |
| Volatility (annualized) | 19.8% | 21.7% |
| Max drawdown | -12.3% (Oct 2025→Mar 2026) | -35.9% (Nov 2021→Oct 2022) |

## Peers
MERDX (Meridian Growth Fund) USD 29.44 -0.00% · RYNVX (Rydex Series Trust - Nova Portf) USD 203.92 +0.00% · GABAX (Gabelli Asset Fund (The)) USD 51.34 -0.00% · RYOIX (Rydex Series Trust Biotechnolog) USD 94.53 +0.00% · RYAIX (Rydex Series Fds, Inverse Nasda) USD 105.36 -0.00%

## More
Full page: https://nexqual.com/RYOCX · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt